בינוקריט 8000 יחבל 0.8 מל
novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 8000 iu / 0.8 ml - erythropoietin
קרניטין תמיסה % 30
abic marketing ltd, israel - levocarnitine - תמיסה - levocarnitine 30 % - levocarnitine - levocarnitine - systemic and myopathic carnitine deficiency.
פרקסיפרין 0.4 מ"ל/ 3800 iu axa
glaxo smith kline (israel) ltd - nadroparin calcium 3800 iu / 0.4 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during heamodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.
פרקסיפרין 0.3 מ"ל / 2850 axa iu
glaxo smith kline (israel) ltd - nadroparin calcium 2850 iu / 0.3 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.
פרקסיפרין 0.6 מ"ל/ 5700 iu axa
glaxo smith kline (israel) ltd - nadroparin calcium 5700 iu / 0.6 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.
פרקסיפרין 0.8 מ"ל/7600 iu axa
glaxo smith kline (israel) ltd - nadroparin calcium 7600 iu / 0.8 ml - solution for injection - nadroparin - prophylactic treatment of venous thromboembolic disease during surgery for patients presenting with moderate or high risk. treatment of constituted deep vein thrombosis. prevention of coagulation in the extra corporeal circuit during haemodialysis. the prophylaxis of thromboembolic disorders in high risk medical patients (respiratory failure and/or respiratory infection and/or cardiac failure) hospitalised in intensive care unit.
דאלאצין % 2 קרם וגינלי
pfizer pfe pharmaceuticals israel ltd - clindamycin phosphate - קרם - clindamycin phosphate 2 %w/w - clindamycin - clindamycin - treatment of bacterial vaginosis only if bacteria susceptible to clindamycin were found.
דאלאצין פתילות ואגינליות
pfizer pfe pharmaceuticals israel ltd - clindamycin as phosphate - פתילות - clindamycin as phosphate 100 mg - clindamycin - clindamycin - dalacin vaginal ovules are indicated for 3-day treatment of bacterial vaginosis in non-pregnant women.
זינט טבליות 125 מג
novartis israel ltd., israel - cefuroxime as axetil - טבליה - cefuroxime as axetil 125 mg - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible micro-organisms.